MeSH term
Frequency | Condition_Probility | Cell Membrane/metabolism | 2 | 0.0 |
DNA Mutational Analysis | 2 | 0.0 |
Hela Cells | 2 | 0.0 |
Humans | 18 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 13 | 0.0 |
Base Sequence | 7 | 0.0 |
DNA, Complementary/biosynthesis | 2 | 3.0 |
Membrane Transport Proteins/biosynthesis/*genetics/metabolism | 2 | 100.0 |
Molecular Sequence Data | 7 | 0.0 |
Thiamine/metabolism | 4 | 57.0 |
Blotting, Northern | 2 | 0.0 |
Cloning, Molecular | 5 | 0.0 |
Transfection | 2 | 0.0 |
Animals | 8 | 0.0 |
Cell Line | 3 | 0.0 |
Chromosome Mapping | 2 | 0.0 |
Mice | 6 | 0.0 |
Research Support, Non-U.S. Gov't | 11 | 0.0 |
Carrier Proteins/*genetics | 6 | 0.0 |
Female | 7 | 0.0 |
Male | 8 | 0.0 |
*Membrane Transport Proteins | 9 | 1.0 |
Pedigree | 3 | 0.0 |
Syndrome | 6 | 0.0 |
Thiamine/therapeutic use | 2 | 66.0 |
Amino Acid Sequence | 6 | 0.0 |
Exons | 2 | 0.0 |
Introns | 3 | 0.0 |
RNA, Messenger/genetics/metabolism | 3 | 0.0 |
Sequence Alignment | 2 | 0.0 |
Sequence Homology, Amino Acid | 5 | 0.0 |
Folic Acid/*metabolism | 2 | 4.0 |
Adolescent | 2 | 0.0 |
Thiamine/*therapeutic use | 3 | 75.0 |
Biological Transport | 3 | 0.0 |
Kinetics | 2 | 0.0 |
Mutagenesis | 2 | 0.0 |
*Mutation | 4 | 0.0 |
Anemia, Megaloblastic/complications/drug therapy/*genetics | 3 | 100.0 |
DNA, Complementary/genetics | 2 | 0.0 |
Deafness/complications/genetics | 2 | 100.0 |
Diabetes Complications | 4 | 2.0 |
Diabetes Mellitus/genetics | 2 | 5.0 |
Comparative Study | 2 | 0.0 |
DNA Primers/genetics | 2 | 0.0 |
Deafness/complications/*genetics | 2 | 50.0 |
Diabetes Mellitus/*genetics | 2 | 6.0 |
Thiamine/*metabolism | 2 | 50.0 |
DNA Primers | 2 | 0.0 |
